FTC seeks contempt order against Shkreli for pharma stock holdings

The FTC has asked a federal court to hold Martin Shkreli in contempt for violating a court order that bans him from the pharmaceutical industry, reportedly by holding pharma stocks. This marks an enforcement escalation against Shkreli, who was previously barred from the industry after his fraud conviction. The outcome could set a precedent for how lifetime industry bans are enforced against individuals.